Table 3.
Patient factors | Deepak et al. 20098 | Sendil et al. 20209 | Umeda et al. 201810 | Rai et al. 202011 | Santoli et al. 202312 | Watson et al. 201613 | Mikhail et al. 2023 |
---|---|---|---|---|---|---|---|
Age | 51 | 63 | 54 | 77 | 62 | 82 | 70 |
Sex | female | male | female | male | male | male | female |
Clinical Presentation | Encephalopathy, Abdominal pain | Cardiac arrest | gastroenteritis | Abdominal pain, nausea, vomiting | Abdominal pain, nausea, vomiting | Nausea and vomiting | Encephalopathy |
Metformin dosage | 1000 mg BID | 1000 mg BID | 1000 mg BID | 1000 mg BID | 1000 mg BID | unknown | 1000 mg BID |
pH level | 6.64 | 6.69 | 6.57 | 6.94 | 6.9 | 6.5 | 6.607 |
Bicarbonate level (mmol/L) | <5 | 4.8 | 2 | 8 | 5 | unknown | 2 |
Creatinine level (mg/dl) | 7.4 | 15.95 | 8.07 | 7.39 | 13.3 | unknown | 8.4 |
Lactic acidosis (mmol/L) | 23.8 | 12 | 16.3 | 13.1 | 11.7 | 28.6 | 20.1 |
Metformin level (mcg/ml) | unknown | 29 | 42 | 23 | unknown | unknown | 35 |
Treatment | CRRT | CRRT | CRRT | CRRT | CRRT | CRRT | CRRT |